Asymmetric Synthesis of Cycloheptanes
FULL PAPER
d=159.8, 152.3, 150.9, 132.7, 129.2, 129.1, 128.8, 128.5, 127.8, 126.2, 116.7,
115.4, 114.9, 79.3, 77.0, 74.0, 65.5, 62.0, 55.5, 33.2, 29.0, 25.2 ppm; [a]D =+
143.1 (c=1.0 in CHCl3); HRMS (ESI):m/Z calcd for [M+Na]+
(C27H26Cl2N2O3): 519.1213; found: 519.1238. The enantiomeric excess was
determined by HPLC with an OD-H column (n-hexane: iPrOH=90:10,
l=250 nm), 1.0 mLminꢀ1; tR =major enantiomer 8.5 min, minor enantio-
mer 11.0 min.
Data for 4g: White solid; 1H NMR (400 MHz, CDCl3): d=7.63–7.59 (m,
2H), 7.28–7.15 (m, 5H), 7.05–6.83 (m, 7H), 4.77 (br d, J=9.2 Hz, 1H),
4.72 (d, J=10.4 Hz, 1H), 4.51 (t, J=6.4 Hz, 1H), 3.87 (s, 3H), 3.83 (dd,
J=2.0, 6.8 Hz, 1H), 2.30–2.00 (m, 4H), 1.86–1.75 ppm (m, 3H);
13C NMR (100 MHz, CDCl3): d=159.6, 153.8, 152.4, 133.4, 129.1, 128.9,
128.6, 122.7, 121.2, 115.4, 114.8, 114.1, 79.3, 77.1, 73.9, 65.8, 62.0, 55.5,
33.3, 29.1, 25.3 ppm; [a]D =+143.1 (c=1.0 in CHCl3); HRMS (ESI) m/z:
calcd. for [M+Na]+ (C27H28N2O3): 451.1992; found: 451.2002. The enan-
tiomeric excess was determined by HPLC with an AD column. (n-
hexane: iPrOH=93:7, l=250 nm), 0.5 mLminꢀ1; tR =major enantiomer
43.4 min, minor enantiomer 23.3 min.
33.1, 32.1, 31.5, 30.9, 29.1, 25.2, 22.3, 14.0 ppm; [a]D =+75.5 (c=1.3 in
CHCl3); HRMS (ESI): m/z calcd for [M+H]+(C26H32N2O2) 405.2537;
found: 405.2548. The enantiomeric excess was determined by HPLC with
an OD-H column (n-hexane: iPrOH=90:10, l=230 nm), 0.5 mLminꢀ1
tR =major enantiomer 12.6 min, minor enantiomer 15.6 min.
;
Synthesis of4m : Catalyst 10 (0.05 mmol, 20 mol%) and a?b unsaturated
aldehyde 1 (0.25 mmol) were added to a small vial containing nitrone de-
rived from benzylamine and banzaldehyde (0.25 mmol, 1.0 equiv.) in
CHCl3 (1.0 mL) . The reaction was stirred at room temperature for 3
days. Then hydroxylphenyl amine (0.25 mmol) was added and the reac-
tion was stirred at room temperature for 4 h. The crude was purified by
column chromatography to afford the desired product. Yellow oil;
1H NMR (400 MHz, CDCl3): d=7.60–7.00 (m, 15H), 4.79 (d, J=9.2 Hz,
1H), 4.73 (t, J=9.2 Hz, 1H), 4.32 (d, J=10.8 Hz, 1H), 4.25 (d, J=
13.6 Hz, 1H), 4.02 (d, J=13.6 Hz, 1H), 4.79 (dd, J=1.6 Hz, 6.4 Hz, 1H),
2.20–1.40 ppm
(m, 7H); 13C NMR (100 MHz, CDCl3): d=152.4, 139.5,
R
137.9, 128.9, 128.9, 128.6, 128.3, 128.1, 127.9, 126.9, 122.5, 115.3, 76.9,
75.5, 63.6, 62.6, 62.3, 33.1, 29.7, 29.1, 25.7 ppm; [a]D =+45.5 (c=0.5 in
CHCl3); HRMS (ESI): m/z calcd for [M+H]+(C27H28N2O2) 413.2224;
found: 413.2221. The enantiomeric excess was determined by HPLC with
Data for 4h: Yellow oil; 1H NMR (400 MHz, CDCl3): d=7.55–7.50 (m,
2H), 7.42–7.38 (m, 2H), 7.34–7.20 (m, 7H), 7.14–7.11 (m, 1H), 7.00–6.88
(m, 4H), 6.54 (dd, J=4.4 Hz, J’=16.0 Hz, 1H), 4.81 (d, J=7.2 Hz, 1H),
4.45–4.37 (m, 2H), 4.02 (dd, J=6.8 Hz, J’=2.0 Hz, 1H), 2.30–2.13 (m,
an OD-H column. (n-hexane: iPrOH=93:7, l=230 nm), 0.5 mLminꢀ1
tR =major enantiomer 13.6 min, minor enantiomer 23.2 min.
;
3H), 2.06–1.70 ppm
(m, 4H); 13C NMR (100 MHz, CDCl3): d=153.8,
G
Typical dihydroxylation procedure: In a round-bottomed flask, com-
pound 4h or 4l (0.25 mmol) was dissolved in an acetone/water (8:1) mix-
ture (1.0 mL). Next, a catalytic amount of OsO4 (2.5% mol%) and N-
methyl morpholine N-oxide (0.75 mmol) were added. The reaction mix-
ture was stirred at room temperature overnight. The crude product was
purified by column chromatography (pentane/EtOAc mixtures) to afford
the desired product 12.
Data for 12h: Yellow oil; 1H NMR (400 MHz, CDCl3): d=7.50–7.10
(m,11H), 7.00–6.90 (m, 4H), 5.12 (s, bs, 1H), 4.78 (d, J=10 Hz, 1H),
4.32–4.18 (m, 3H), 4.04 (d, J=6.4 Hz, 1H), 2.30–1.20 ppm (m, 7H);
13C NMR (100 MHz, CDCl3): d=152.5, 152.4, 141.4, 129.1, 128.7, 128.6,
127.8, 125.9, 122.4, 121.7, 115.3, 114.5, 78.9, 78.2, 72.1, 70.7, 64.2, 61.7,
33.4, 31.9, 25.1, 22.6 ppm; [a]D =+64.5 (c=1.0 in CHCl3); HRMS (ESI):
m/z calcd for [M+Na]+ (C28H30N2O4): 459.2278; found: 459.2259.
Data for 12l: Yellow oil; 1H NMR (400 MHz, CDCl3): d=7.30–6.90 (m,
10H), 4.79 (m., 1H), 4.40–4.00 (m, 5H), 2.20–1.10 (m, 15H), 0.87 ppm(t,
J=7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=152.4, 152.4, 130.8,
129.0, 128.8, 128.2, 115.4, 114.4, 78.7, 74.8, 72.2, 70.1, 68.1, 64.1, 60.4, 36.7,
31.9, 30.3, 29.3, 23.7, 22.7, 14.0 ppm; [a]D =+21.5 (c=0.2 in CHCl3);
HRMS (ESI): m/z calcd for [M+Na]+ (C26H34N2O4): 461.2411, found:
461.2410.
152.2, 136.3, 132.6, 130.1, 128.9, 128.8, 128.8, 128.1, 126.6, 122.5, 121.4,
115.2, 114.3, 78.4, 77.2, 73.2, 62.1, 61.9, 33.1, 29.1, 25.2 ppm; [a]D =+
260.5 (c=1.0 in CHCl3); HRMS (ESI): m/z calcd for [M+H]+
(C28H28N2O2) 425.2224; found: 425.2228. The enantiomeric excess was de-
termined by HPLC with an OD-H column. (n-hexane: iPrOH=90:10,
l=250 nm), 0.5 mLminꢀ1; tR =major enantiomer 9.6 min, minor enantio-
mer 12.3 min.
Data for 4i: Yellow solid; 1H NMR (400 MHz, CDCl3): d=8.33–8.30 (m,
1H), 8.18–8.15 (m, 1H), 7.55–7.48 (m, 3H), 7.42–7.36 (m, 2H), 7.29–7.20
(m, 3H), 7.13–7.08 (m, 2H), 7.00–6.84 (m, 3H), 6.53 (dd, J=7.6 Hz,
16.0 Hz, 1H), 4.81 (d, J=7.2 Hz, 1H), 4.44–4.37 (m, 2H), 4.01 (dd, J=
1.6 Hz, 6.4 Hz, 1H), 2.28–2.15 (m, 3H), 2.10–1.68 ppm
(m, 4H). 13C NMR
U
(100 MHz, CDCl3): d=153.9, 152.3, 135.4, 132.1, 131.8, 131.4, 131.0,
129.8, 129.1, 129.0, 128.9, 128.2, 125.7, 122.8, 122.5, 122.1, 121.6, 115.4,
114.4, 78.5, 77.4, 73.1, 62.3, 62.1, 33.2, 29.2, 25.3 ppm; [a]D =+129.4 (c=
1.0 in CHCl3);. HRMS (ESI): m/z calcd for [M+Na]+ (C28H27BrN2O2):
525.1148; found: 525.1157. The enantiomeric excess was determined by
HPLC with an AD column (n-hexane: iPrOH=93:7, l=250 nm),
1.0 mLminꢀ1
44.8 min.
;
tR =major enantiomer 51.6 min, minor enantiomer
Data for 4j: Yellow oil; 1H NMR (400 MHz, CDCl3): d=7.55–7.15 (m,
10H), 6.95–6.83 (m, 5H), 6.52 (dd, J=8.4 Hz, J’=16.0 Hz, 1H), 4.81 (d,
J=10 Hz, 1H), 4.41–4.34 (m, 2H), 4.01 (dd, J=6.8 Hz, J’=2.0 Hz, 1H),
2.30–1.65 ppm (m, 7H); 13C NMR (100 MHz, CDCl3): d=152.4, 152.1,
136.1, 132.8, 129.7, 128.9, 128.8, 128.7, 128.2, 126.6, 126.3, 122.6, 115.6,
115.2, 78.5, 77.2, 73.6, 62.1, 61.9, 33.1, 29.0, 25.1 ppm; [a]D =+125 (c=1.0
in CHCl3); HRMS (ESI): m/z calcd for [M+Na+](C28H27ClN2O2)
481.1653, found 481.1655. The enantiomeric excess was determined by
HPLC with an OD-H column (n-hexane: iPrOH=90:10, l=250 nm),
0.5 mLminꢀ1; tR =major enantiomer 8.5 min, minor enantiomer 13.9 min.
Typical experimental procedure for aldehyde formation: In a round-bot-
tomed flask, diol 12 (0.2 mmol) was dissolved in a THF:water (1:1, 2 mL)
mixture. Next, NaIO4 (1.0 mmol) was added and the reaction was stirred
at room temperature overnight. The crude product was purified by
column chromatography (pentane:EtOAc mixtures) to afford the desired
product 13.
Data for 13l: Yellow oil; 1H NMR (400 MHz, CDCl3): d=9.96 (d, J=
4.0 Hz, 1H), 7.20–6.90 (m, 10H), 4.83 (d, J=9.2 Hz, 1H), 4.34–4.20 (m,
2H). 4.1 (d, J=6.4 Hz, 1H), 2.40–2.30 (m, 2H), 2.00–1.00 ppm (m, 5H);
13C NMR (100 MHz, CDCl3): d= 202.1, 152.5, 151.9, 129.1, 128.9, 122.7,
122.0, 115.3, 113.7, 78.4, 76.4, 62.3, 58.1, 32.8, 31.9, 24.7, 22.7 ppm; [a]D =
+33.1 (c=1.0 in CHCl3); HRMS (ESI): m/z calcd for [M+Na]+
(C21H22N2O3) 373.1523, found 373.1540.
Data for 4k: Yellow oil; 1H NMR (400 MHz, CDCl3): d=7.55–7.15 (m,
10H), 6.95–6.83 (m, 5H), 6.52 (dd, J=8.4 Hz, J’=16.0 Hz, 1H), 4.80 (d,
J=9.6 Hz, 1H), 4.41–4.35 (m, 2H), 3.97 (dd, J=6.8 Hz, J’=2.0 Hz, 1H),
2.30–1.65 ppm (m, 7H); 13C NMR (100 MHz, CDCl3): d=153.8, 150.9,
136.2, 132.7, 130.0, 128.9, 128.8, 128.2, 127.5, 126.6, 121.5, 116.5, 114.3,
78.3, 77.2, 73.3, 62.2, 61.8, 33.1, 29.0, 25.2 ppm; [a]D =+147.5 (c=1.0 in
CHCl3); HRMS (ESI): m/z calcd for [M+H+](C28H27ClN2O2) 459.1847,
found 459.1834. The enantiomeric excess was determined by HPLC with
Acknowledgements
an OD-H column. (n-hexane: iPrOH=90:10, l=250 nm), 0.5 mLminꢀ1
tR =major enantiomer 21.3 min, minor enantiomer 24.4 min.
;
We gratefully acknowledge the Swedish National Research Council,
Wenner-Gren Foundation, Magnus Bergvall Foundation, and Carl Tryg-
ger Foundation for financial support. A.C. is grateful recipients of the
city of Stockholm inventor award.
Data for 4l: Yellow oil; 1H NMR (400 MHz, CDCl3): d=7.30–6.80 (m,
10H), 6.10–6.00 (m, 1H), 5.80–5.70 (m, 1H), 4.80 (d, J=9.6 Hz, 1H),
4.34–4.19 (m, 2H) 3.94 (dd, J=6.4 Hz, 1.6 Hz, 1H), 2.25–1.20 (m, 13H),
0.97 (t, J=7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=154.1, 152.4,
134.7, 130.7, 128.8, 128.6, 122.4, 121.1, 115.2, 114.3, 78.1, 73.1, 62.4, 61.6,
Chem. Eur. J. 2008, 14, 2693 – 2698
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2697